IO Biotech, Inc.·4

Aug 9, 8:41 PM ET

Sullivan Amy 4

4 · IO Biotech, Inc. · Filed Aug 9, 2023

Insider Transaction Report

Form 4
Period: 2023-08-09
Sullivan Amy
Chief Financial Officer
Transactions
  • Award

    Warrants (Right to Buy)

    2023-08-09$0.13/sh+49,382$6,17349,382 total
    Exercise: $2.47From: 2023-08-09Common Stock (49,382 underlying)
  • Award

    Common Stock

    2023-08-09$1.90/sh+49,382$93,82674,382 total
Footnotes (1)
  • [F1]These Warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition of the Issuer, as defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023.

Documents

1 file
  • 4
    form4.xmlPrimary